Piggy-back graft for liver transplantation.

Cochrane Database Syst Rev

Department of Surgery, Royal Free Campus, UCL Medical School, 9th Floor, Royal Free Hospital, Pond Street, London, UK, NW3 2QG.

Published: January 2011

Background: Piggy-back method of transplantation, which involves preservation of the recipient retrohepatic inferior vena cava, has been suggested as an alternative to the conventional method of liver transplantation, where the recipient retrohepatic inferior vena cava is resected.

Objectives: To compare the benefits and harms of piggy-back technique versus conventional liver transplantation as well as of the different modifications of piggy-back technique during liver transplantation.

Search Strategy: We searched The Cochrane Hepato-Biliary Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Index Expanded until June 2010 for identifying randomised trials using search strategies.

Selection Criteria: Only randomised clinical trials, irrespective of language, blinding, or publication status were considered for the review.

Data Collection And Analysis: Two authors (KSG and VP) independently identified trials and independently extracted data. We calculated the mean difference (MD) or standardised mean difference (SMD) with 95% confidence intervals (CI) using both the fixed-effect and the random-effects models with RevMan 5 based on intention-to-treat analysis for continuous outcomes. For binary outcomes, we used the Fisher's exact test since none of the comparisons of binary outcomes included more than one trial.

Main Results: Two trials randomised in total 106 patients to piggy-back method (n = 53) versus conventional method with veno-venous bypass (n = 53). Both trials were at high risk of bias. There was no significant difference in post-operative mortality, primary graft non-function, vascular complications, renal failure, transfusion requirements, intensive therapy unit (ITU) stay, or hospital stay between the two groups. The warm ischaemic time was significantly shorter in the piggy-back method than the conventional method (MD -11.50 minutes; 95% CI -19.35 to -3.65; P < 0.01). The proportion of patients who developed chest complications were significantly higher in the the piggy-back method than the conventional method (75.8% versus 44.1%; P = 0.01).One trial randomised 80 patients to piggy-back with porto-caval bypass (n = 40) versus piggy-back without porto-caval bypass (n = 40). This trial was at high risk of bias. There was no significant difference in post-operative mortality, re-transplantation due to primary graft non-function, vascular complications, renal failure, or hospital stay between the two groups. Fewer patients required blood transfusion in the piggy-back with porto-caval bypass group (55%) than the piggy-back without porto-caval bypass group (75%) (P = 0.02). There was no significant difference in the mean amount of blood transfused between the groups (MD -1.00 unit; 95% CI -2.19 to 0.19; P = 0.10). The ITU stay was significantly shorter in the piggy-back with porto-caval bypass group (2.9 days) than the piggy-back without porto-caval bypass group (4.9 days; MD -2.00 days; 95% CI -3.82 to -0.18; P = 0.03).There were no trials comparing piggy-back method with conventional method without veno-venous bypass or different techniques of piggy-back method.

Authors' Conclusions: There is currently no evidence to recommend or refute the use of piggy-back method of liver transplantation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD008258.pub2DOI Listing

Publication Analysis

Top Keywords

piggy-back method
24
piggy-back porto-caval
24
porto-caval bypass
24
conventional method
20
piggy-back
16
liver transplantation
16
bypass group
16
method conventional
12
method
11
recipient retrohepatic
8

Similar Publications

Article Synopsis
  • Outpatient management of febrile neutropenia (FN) in pediatric cancer patients has shown to be as safe and effective as inpatient care, prompting this cost-minimization analysis (CMA) in Mexico.
  • The study analyzed data from 117 FN episodes, finding that outpatient management resulted in an average savings of $1,087 per episode, equating to a 92% reduction in total costs compared to inpatient treatment.
  • The findings suggest that outpatient care is more cost-effective, supporting its implementation in the Mexican public health care system for managing FN in children with cancer.
View Article and Find Full Text PDF

Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients: a quasi-experimental study.

J Hosp Infect

September 2024

Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals, Geneva, Switzerland; Infection Antimicrobials Modeling Evolution (IAME) U 1137, INSERM, Université Paris-Cité, Paris, France. Electronic address:

Background: Continuous fluid infusions delivered between therapies by piggy-back systems avoid disconnection and reconnection of central venous catheters (CVCs), thereby reducing opportunities for line contamination. However, the impact of continuous versus intermittent infusions on central line-associated bloodstream infections (CLABSIs) is unknown.

Aim: To investigate the effect of temporary infusion interruption and line disconnection, with or without use of a 70% isopropyl alcohol cap (IPA-C) on CLABSI rates in haematology patients.

View Article and Find Full Text PDF

Background: There is continuous growth of combined liver-kidney transplantation (CLKTx) numbers with remarkable outcomes, especially among patient with liver cirrhosis and end-stage renal disease. The aim was to present a single center experience.

Methods: Twenty patients (9 males) with a mean age of 48 (range: 20-62) years underwent CLKTx from 2005 to 2022.

View Article and Find Full Text PDF

The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.

PLoS One

December 2022

Winton Centre for Risk & Evidence Communication, Department of Pure Mathematics & Mathematical Statistics, University of Cambridge, Cambridge, United Kingdom.

Background: Trastuzumab is a valuable therapy option for women with ERBB2(HER2)+ breast cancer tumours, often used in combination with chemotherapy and alongside other therapies. It is known to have adverse effects, but these have proved difficult to separate from the effects of other concurrent therapies patients are usually taking. This study aims to assess the adverse effects specifically attributable to trastuzumab, and whether they vary by patient subgroup or concurrent therapies.

View Article and Find Full Text PDF
Article Synopsis
  • * Conducted as a community-based, randomized controlled trial, it will involve 780 women and 468 children receiving monthly salt supplies for a year, measuring changes in various micronutrient biomarkers and gut microbiome composition.
  • * If successful, the fortified salt could significantly reduce micronutrient deficiencies and potentially be scaled up quickly using existing iodized salt infrastructure in India and beyond.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!